{"schema_version":"secwatch.filing_event.v1","accession":"0001367644-23-000127","form_type":"8-K","ticker":"EBS","cik":"0001367644","company_name":"Emergent BioSolutions Inc.","filed_at":"2023-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.581958+00:00","generated_at":"2026-06-13T16:07:53.487518+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Emergent BioSolutions CEO Robert Kramer retires; Haywood Miller named interim CEO","bullets":["Robert Kramer resigned as President/CEO and director effective June 24, 2023; will advise until Aug 1.","Haywood Miller, managing director at Berkeley Research Group, appointed interim CEO immediately.","Miller receives $125K/month cash compensation until permanent CEO is named or June 24, 2024.","Board to conduct search for permanent CEO with assistance from executive search firm.","Company highlights 2023 transformation including sale of travel health business and ACAM2000 contract extension."],"urls":{"canonical":"https://secwatch.observer/filing/0001367644-23-000127","json":"https://secwatch.observer/filing/0001367644-23-000127.json","markdown":"https://secwatch.observer/filing/0001367644-23-000127.md","text":"https://secwatch.observer/filing/0001367644-23-000127.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000127/0001367644-23-000127-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000127/ebs-20230623.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T16:07:53.487518+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"14cd8db97a","claim":"Haywood Miller was appointed as interim Chief Executive Officer at Emergent BioSolutions Inc..","evidence_excerpt":"On June 24, 2023, the Board appointed Haywood Miller of Berkeley Research Group to serve as a non-employee interim Chief Executive Officer, effective immediately, until the Board’s search for a permanent Chief Executive Officer is completed.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000127/0001367644-23-000127-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"177972a58a","claim":"Robert G. Kramer Sr. resigned as President and Chief Executive Officer at Emergent BioSolutions Inc..","evidence_excerpt":"On June 23, 2023, Robert G. Kramer Sr. notified the Board of Directors (the “Board”) of Emergent BioSolutions, Inc. (the “Company”) of his intent to retire from the Company on August 1, 2023 and to resign from his positions as President and Chief Executive Officer and as a director, effective June 24, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000127/0001367644-23-000127-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}